Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 874 results for "ranbaxy industries"

Ranbaxy loss widens
Calcutta Telegraph

Ranbaxy December quarter net loss widens on forex loss

Ranbaxy, which is being acquired by larger local rival Sun Pharmaceutical Industries Ltd for $3.2 billion, has been hit by a series of regulatory sanctions in the past year due to poor production practices at its India-based plants. DON'T MISS any stories, ... Economic Times, 1 day ago
Ranbaxy loss widens Calcutta Telegraph, 1 day ago
DNA India

FDA Backs Teva Pharmaceutical Industries Limited (TEVA)'s Generic Nexium in Blow to AstraZeneca PLC (AZN), Ranbaxy Laboratories (RANBAXY.BO) 1/27/2015

JERUSALEM--( BUSINESS WIRE )--Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announces the Food and Drug Administration (FDA) approval of the first generic equivalent to Nexium (esomeprazole magnesium) Delayed-Release Capsules in ...
 ClinicSpace2 days ago Ranbaxy suffers fresh jolt  24Dunia1 day ago Ranbaxy loses generic exclusivity over $6 billion Nexium market  DNA India2 days ago Ranbaxy loses US generic exclusivity over $6 bn Nexium [DNA : Daily News & Analysis (India)]  Pharmacy Choice16 hours ago
Business Today India

Why BioLight Life Sciences' India entry is good news for Dilip Shanghvi

Email this Print After a dream run with the Ranbaxy acquisition, Sun Pharmacheutical Industries founder Dilip Shanghvi's fortune seems on an uptrend. Israel-based BioLight Life Sciences, in which he holds 21.45 per cent, is gearing for its India ...
 Smart Investor1 week ago Sun Pharma open to fresh acquisitions: Dilip S Shanghvi  FirstWord Pharma4 days ago You have to take business risks: Dilip Shanghvi  Business Today India1 day ago Pharma shares under pressure; CNX Pharma index down nearly 4%  Business Standard India1 month ago
India Infoline

Sensex, Nifty off record high; Asian Paints, Ranbaxy rally

HDFC, ICICI Bank, TCS, Sun Pharma, Maruti Suzuki and Coal India gained 1-1.5 percent. HDFC Bank, Reliance Industries, Infosys, SBI, ONGC and Dr Reddy's Labs advanced 0.5-0.8 percent.
 Money Control1 day ago Sensex closes above 29,000, Nifty ends at lifetime high of 8,761  India Infoline1 week ago Nifty hits new life high, HDFC and Axis Bank lead gains  Firstpost.com1 week ago
Money Control

Stocks in news: TVS Motor, SBI, Ranbaxy, Hindalco, Maruti

Hindalco Industries | TVS Motor | SBI | Ranbaxy Labs | Maruti Suzuki | Idea Cellular | United Spirits | City Union Bank | Tata Coffee | Persistent Systems | SpiceJet | UltraTech Cement | Rane Brake | Bharat Bijlee | Bharat Electronics | Max India | ONGC | ...
 Money Control3 days ago Stocks in news: Bharti, Idea, Titan, LT, Ranbaxy, Hindalco  Money Control2 days ago
Business Standard India

Sun Pharma and Ranbaxy receives CCI approval for acquisition

Posted On: 2014-12-08 21:23:36 Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) and Ranbaxy Laboratories Ltd (Reuters: RANB.BO, Bloomberg: RBXY IN, NSE: RANBAXY, BSE: 500359) have announced that ...
 Equity Bulls1 month ago Pharmaceutical Newsletter - December 08 to 12, 2014  India Infoline1 month ago CCI approves Ranbaxy acquisition by Sun Pharma  HDFC Securities1 month ago Sun Pharma and Ranbaxy Lab will be in focus after CCI approves merger  Business Standard1 month ago

Here are top 10 stocks to keep an eye on November 20

Here are top 10 stocks to keep an eye on November 20 - Axis Bank, Wockhardt, DLF, Ranbaxy, Alok Industries, Kotak Mahindra Bank, ING Vysya, Hindalco, Jindal Steel and Pennar Industries.
 Money Control2 months ago Stocks in news: MM, Axis, Sadbhav, MCX, Ranbaxy, ICICI  Money Control1 month ago Stocks in news: Ranbaxy, Mangalore Chemicals, Mastek, SAIL  Money Control1 month ago SBI, ICICI Bank, Hathway Cable top buys: Reliance MF  Moneycontrol.com20 hours ago

Sun Pharma, Ranbaxy shares surge after CCI approval

Sun Pharmaceutical Industries stock gained 1.4 per cent, while shares of Ranbaxy Laboratories were up over 3 per cent on Tuesday after the Competition Commission of India (CCI) approved Sun Pharma's US $3.2 billion bid to buy Ranbaxy. Shares of ...
 Business Today India1 month ago Sun Pharma, Ranbaxy gain on CCI approval  India Infoline1 month ago Ranbaxy shares slump 5%; mcap down Rs 1,072 crore  The Financial Chronicle2 months ago

Sun Pharma gains after CCI approves merger between Sun Pharma and Ranbaxy

Sun Pharmaceutical Industries rose 1.83% to Rs 843.95 at9:30 IST on BSE after the Competition Commission of India in its meeting held on 5 December 2014, approved the proposed merger between Sun Pharmaceutical Industries and Ranbaxy Laboratories. ...
 Capital Market1 month ago

Sun Pharma, Ranbaxy Laboratories rallies over 3% post CCI nod on deal

NEW DELHI: Sun Pharmaceutical Industries, Ranbaxy Laboratories rose over 3 per cent each in trade on Tuesday, after the Competition Commission of India approved the acquisition of generic drugmaker Ranbaxy by bigger rival Sun Pharma on the condition ...
 Economic Times1 month ago Sun Pharma clarifies on CCI approval  India Infoline1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less